Abemaciclib
From IDWiki
Revision as of 12:27, 17 September 2024 by Aidan (talk | contribs) (Created page with "* Small-molecule inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) * Indicated for breast cancer (HR positive, HER2 negative) * Major adverse effects include diarrhea (most common), myelosuppression with neutropenia and rare febrile neutropenia, increased creatinine, DVT/PE, hepatocellular hepatotoxicity, pneumonitis, and increase in infections Category:Medications Category:Oncology")
- Small-molecule inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6)
- Indicated for breast cancer (HR positive, HER2 negative)
- Major adverse effects include diarrhea (most common), myelosuppression with neutropenia and rare febrile neutropenia, increased creatinine, DVT/PE, hepatocellular hepatotoxicity, pneumonitis, and increase in infections
